Alan is a dynamic researcher with a wide range of experiences in modeling cancer and diabetes using next-generation in vitro models such as organoids and spheroids. Before joining Volastra, Alan’s research focused on the influence of mechanical and inflammatory cues on tumors and macrophage activity. He received his bachelor’s degree in biology from Harvard University and his Ph.D. in bioengineering from Cornell University.